journal article·2017-09

Design and Construction of a Smart Targeting Drug Delivery System Based on Phototriggered Competition of Host–Guest Interaction

Dan Zhao, Xiaoqing Yi, Gongdao Yuan, Renxi Zhuo, Feng Li

Macromolecular Bioscience· Volume 17· Issue 9
Publisher page

Abstract

A smart targeting drug delivery nanocarrier is successfully constructed based on phototriggered competition of host–guest interaction. The targeting motif, i.e., biotin is first concealed by β‐cyclodextrin (β‐CD) via host–guest interaction. When the nanoparticles are exposed to UV light, the cleavage of photosensitive groups results in the exposure of adamantane (Ad) groups initially located in the interior of nanoassemblies, and β‐CDs capped on biotin ligands can be replaced by Ad because of the higher binding constant between Ad and β‐CD than that between biotin and β‐CD. The competition of host–guest interaction leads to the recovery of targeting capacity of biotin ligands on the nanocarriers. By virtue of photoregulation, the nanocarriers exhibit controllable ligand‐receptor recognition, which is proved by flow cytometry, laser confocal microscopy, and cytotoxicity assay. This strategy has a potential to improve the selectivity and safety of targeting drug delivery systems.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Photochromic and Fluorescence Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Biomedical Polymers of Ministry of Education College of Chemistry and Molecular Science Wuhan University Wuhan 430072 China

Funding

National Natural Science Foundation of China

References (33)

Show source-provided references
1. 10.1021/nn404676w10.1021/nn404676w ↗
2. 10.1021/acsami.6b0473710.1021/acsami.6b04737 ↗
3. 10.1002/adfm.20160177010.1002/adfm.201601770 ↗
4. 10.1021/acsami.6b0042610.1021/acsami.6b00426 ↗
5. 10.1021/ma200898n10.1021/ma200898n ↗
6. 10.1002/adhm.20140073610.1002/adhm.201400736 ↗
7. 10.1039/C5PY01808K10.1039/C5PY01808K ↗
8. 10.1021/acs.biomac.6b0095610.1021/acs.biomac.6b00956 ↗
9. 10.1002/anie.20120333910.1002/anie.201203339 ↗
10. 10.1002/smll.20140258110.1002/smll.201402581 ↗
11. 10.1002/mabi.20120047510.1002/mabi.201200475 ↗
12. 10.1021/nl047998710.1021/nl0479987 ↗
13. 10.1002/mabi.20130012910.1002/mabi.201300129 ↗
14. 10.1016/j.jconrel.2016.11.01110.1016/j.jconrel.2016.11.011 ↗
15. 10.1021/acs.molpharmaceut.5b0071210.1021/acs.molpharmaceut.5b00712 ↗
16. 10.1016/j.bios.2015.12.05810.1016/j.bios.2015.12.058 ↗
17. 10.1002/smll.20160113710.1002/smll.201601137 ↗
18. 10.1016/j.jconrel.2015.12.00610.1016/j.jconrel.2015.12.006 ↗
19. 10.1039/C4CC04056B10.1039/C4CC04056B ↗
20. 10.1002/adfm.20160170310.1002/adfm.201601703 ↗
21. 10.1002/mabi.20160003210.1002/mabi.201600032 ↗
22. 10.1002/smll.20130192610.1002/smll.201301926 ↗
23. 10.1002/adfm.20130130910.1002/adfm.201301309 ↗
24. 10.1021/nl403733z10.1021/nl403733z ↗
25. 10.1021/nl903411s10.1021/nl903411s ↗
26. 10.1021/la301963v10.1021/la301963v ↗
27. 10.1021/ja075139p10.1021/ja075139p ↗
28. 10.1002/anie.20110160410.1002/anie.201101604 ↗
29. 10.1021/ma101997310.1021/ma1019973 ↗
30. 10.1039/c2cc34225a10.1039/c2cc34225a ↗
31. 10.1039/C6TB03211G10.1039/C6TB03211G ↗
32. 10.1016/j.jconrel.2016.07.01110.1016/j.jconrel.2016.07.011 ↗
33. 10.1039/C6NR04091H10.1039/C6NR04091H ↗